Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Economic Times
The Economic Times
Business
Kumar Gaurav

Gland Pharma shares: Promoter Fosun Pharma likely to divest 5% equity worth Rs 2,279 crore via block deal

Fosun Pharma is likely to divest 5% equity in Gland Pharma via a block deal, according to reports. Fosun Pharma Industrial, the promoter of the company, holds 8,53,93,894 shares or 51.77% stake in the pharmaceutical company as of the quarter ended June 30, 2026, as per BSE data.

According to reports, a block deal has been launched in Gland Pharma through which Fosun Pharma will offload its stake. The floor price for the block deal is set at Rs 2,763 per share, which is at a discount of up to 5% to the current market price.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.